Product Information
FLUOCINONIDE 0.05% GEL is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $1.0842 per GM under NDC 45802076115. Its NADAC has been published 69 times since Jun 11, 2025.
FDA first approved this application on Jun 19, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the fluocinonide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.5 mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802076115
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
FLUOCINONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209030FDA Approved
6/19/2018
TE Code
AB
On Market Since
4/10/2025
Pharmacological Classes
Price Statistics
The NADAC for FLUOCINONIDE 0.05% GEL has been published 69 times since Jun 11, 2025, and over the history we have for it it has declined 10.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0842 per GM |
|---|---|
| All-time high | $1.2507 (Mar 11, 2026) |
| All-time low | $0.9925 (Oct 22, 2025) |
| 52-week high | $1.2507 |
| 52-week low | $0.9925 |
| Median price | $1.1485 |
| Average price | $1.1323 |
| Largest weekly change | +12.5% (Jan 21, 2026) |
| Weeks tracked | 69 |
| Tracking since | Jun 11, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 45% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fluocinonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUOCINONIDE 0.05% GEL?
The current National Average Drug Acquisition Cost (NADAC) for FLUOCINONIDE 0.05% GEL, manufactured by Padagis Israel Pharmaceuticals Ltd, is $1.0842 per GM (NDC 45802076115), effective Sep 30, 2026.
How has the price of FLUOCINONIDE 0.05% GEL changed over time?
Over the history we have for it, the NADAC for FLUOCINONIDE 0.05% GEL has declined 10.7%. It has been tracked across 69 weekly CMS publications since Jun 11, 2025.
What are the highest and lowest recorded NADAC prices for FLUOCINONIDE 0.05% GEL?
Since Jun 11, 2025, the NADAC for FLUOCINONIDE 0.05% GEL has ranged from a low of $0.9925 (Oct 22, 2025) to a high of $1.2507 (Mar 11, 2026), with a median of $1.1485 per GM.
Are there cheaper alternatives to FLUOCINONIDE 0.05% GEL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FLUOCINONIDE 0.05% GEL, is $0.6004 per GM — about 45% below FLUOCINONIDE 0.05% GEL.
Who manufactures FLUOCINONIDE 0.05% GEL?
FLUOCINONIDE 0.05% GEL (NDC 45802076115) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.